Grufity logoGrufity logo

Iqvia Holdings Inc Stock Research

IQV

188.35USD+0.35(+0.19%)Delayed

Market Summary

USD188.35+0.35
Delayed
0.19%

IQV Alerts

IQV Stock Price

IQV RSI Chart

IQV Valuation

Market Cap

35.0B

Price/Earnings (Trailing)

32.06

Price/Sales (Trailing)

2.43

EV/EBITDA

11.61

Price/Free Cashflow

15.48

IQV Price/Sales (Trailing)

IQV Profitability

EBT Margin

9.46%

Return on Equity

18.92%

Return on Assets

4.31%

Free Cashflow Yield

6.46%

IQV Fundamentals

IQV Revenue

Revenue (TTM)

14.4B

Revenue Y/Y

2.83%

Revenue Q/Q

4.97%

IQV Earnings

Earnings (TTM)

1.1B

Earnings Y/Y

-28.62%

Earnings Q/Q

-19.79%

Price Action

52 Week Range

165.75254.94
(Low)(High)

Last 7 days

-4.1%

Last 30 days

-10.7%

Last 90 days

-7.6%

Trailing 12 Months

-16.2%

IQV Financial Health

Current Ratio

0.89

IQV Investor Care

Buy Backs (1Y)

2.57%

Diluted EPS (TTM)

5.72

Peers (Alternatives to Iqvia Holdings)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
38.9B
6.8B
-7.12% -2.94%
31.04
5.68
8.37% 3.64%
35.0B
14.4B
-10.73% -16.15%
32.06
2.43
3.86% 12.94%
34.8B
4.6B
9.07% -35.87%
-7.89
7.58
1.28% -677.95%
9.9B
4.0B
-11.55% -31.05%
20.3
2.48
12.31% 24.36%
MID-CAP
5.7B
1.5B
-7.14% 13.35%
23.05
3.87
27.80% 34.93%
3.6B
5.4B
-7.30% -56.29%
13.33
0.66
3.46% 13.48%
2.6B
278.3M
-26.06% -48.44%
-16.69
9.26
92.72% 15.56%
2.1B
509.7M
26.37% -5.44%
-14.51
4.11
5.24% -1628.17%
SMALL-CAP
680.4M
-
-13.75% -31.50%
-13.59
291.16
-34.21% -22.31%
255.3M
138.6M
-29.45% -81.04%
-7.6
1.84
32.30% -57.86%
199.8M
80.7M
-24.99% -55.14%
7.06
4.15
13.30% 130.72%
143.9M
60.3M
-71.28% -88.95%
-0.29
2.39
17.51% -38.93%
121.4M
65.0M
-18.24% -68.45%
-1.07
1.87
-23.92% -73.73%

Financials for Iqvia Holdings

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue0.7%14,41014,30714,13614,03313,874
Gross Profit3.7%3,2083,0952,988--
  S&GA Expenses2.0%2,0712,0302,0112,0101,964
EBITDA1.1%2,9092,8772,8622,829-
EBITDA Margin0.4%0.20*0.20*0.20*0.20*-
Earnings Before Taxes-6.9%1,3631,4641,3771,2711,128
EBT Margin-7.6%0.09*0.10*0.10*0.09*-
Interest Expenses10.1%416378362362375
Net Income-7.7%1,0911,1821,1601,079966
Net Income Margin-8.4%0.08*0.08*0.08*0.08*-
Free Cahsflow-5.5%2,2602,3922,3732,583-
Balance Sheet
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets4.6%25,33724,22324,41324,96924,689
  Current Assets4.8%4,9814,7524,9114,7724,763
    Cash Equivalents-4.6%1,2161,2741,4281,3871,366
  Net PPE4.9%532507529531497
  Goodwill5.6%13,92113,17713,10413,53213,301
Liabilities3.7%19,57218,87619,06119,05018,647
  Current Liabilities6.2%5,5785,2535,1045,1575,241
    LT Debt, Current0.7%15215115290.0091.00
    LT Debt, Non Current2.9%12,59512,24312,61512,54712,034
Shareholder's Equity7.8%5,7655,3475,3525,9196,042
  Retained Earnings7.3%3,3343,1072,8242,5682,243
Accumulated Depreciation-765----
Shares Outstanding-0.1%186186187189191
Minority Interest------
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-5.5%2,2602,3922,3732,5832,942
  Share Based Compensation9.0%194178165168170
Cashflow From Investing7.8%-2,006-2,176-2,554-2,540-2,103
Cashflow From Financing-20.1%-329-274-89.00-923-1,235
  Buy Backs-10.6%1,1681,3071,192747406

Risks for IQV

What is the probability of a big loss on IQV?

41.1%


Probability that Iqvia Holdings stock will be more than 20% underwater in next one year

35%


Probability that Iqvia Holdings stock will be more than 30% underwater in next one year.

18.5%


Probability that Iqvia Holdings stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does IQV drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Iqvia Holdings was unfortunately bought at previous high price.

Drawdowns

Returns for IQV

Cumulative Returns on IQV

16.6%


7-Year Cumulative Returns

13.6%


5-Year Cumulative Returns

24.8%


3-Year Cumulative Returns

What are the long-term rolling returns for IQV?

FIve years rolling returns for Iqvia Holdings.

Annualized Returns

Which funds bought or sold IQV recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-15
B. Riley Wealth Advisors, Inc.
added
24.26
283,316
985,316
0.03%
2023-03-10
VICTORY CAPITAL MANAGEMENT INC
added
3.39
3,371,390
23,262,400
0.03%
2023-03-08
SHEETS SMITH WEALTH MANAGEMENT
reduced
-2.32
1,198,050
12,614,100
1.97%
2023-03-06
Rockefeller Capital Management L.P.
added
397
16,441,000
19,990,000
0.10%
2023-03-06
NORTH STAR ASSET MANAGEMENT INC
unchanged
-
151,003
1,299,000
0.08%
2023-03-02
OLIVER LAGORE VANVALIN INVESTMENT GROUP
new
-
13,933
13,933
0.01%
2023-03-02
LORING WOLCOTT & COOLIDGE FIDUCIARY ADVISORS LLP/MA
new
-
63,819,400
63,819,400
0.79%
2023-02-28
Voya Investment Management LLC
reduced
-0.45
26,933,400
240,646,000
0.34%
2023-02-27
ST GERMAIN D J CO INC
new
-
23,562
23,562
0.01%
2023-02-24
SRS Capital Advisors, Inc.
sold off
-100
-4,000
-
-%

1–10 of 48

Latest Funds Activity

Are funds buying IQV calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own IQV
No. of Funds

Iqvia Holdings News

MarketBeat

Maryland State Retirement & Pension System Takes Position in ....

MarketBeat,
6 hours ago

MarketWatch

Yahoo Finance

Nasdaq

S&P 500 Analyst Moves: IQV.

Nasdaq,
12 days ago

Schedule 13G FIlings of Iqvia Holdings

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
11.55%
21,447,600
SC 13G/A
Feb 07, 2023
blackrock inc.
8.5%
15,763,249
SC 13G/A
Feb 07, 2022
blackrock inc.
7.9%
15,139,662
SC 13G/A
Feb 10, 2021
vanguard group inc
10.93%
20,954,687
SC 13G/A
Jan 29, 2021
blackrock inc.
7.7%
14,826,277
SC 13G/A
Feb 10, 2020
vanguard group inc
10.03%
19,475,899
SC 13G/A
Feb 10, 2020
vanguard group inc
9.97%
19,346,266
SC 13G/A
Feb 05, 2020
blackrock inc.
7.6%
14,685,767
SC 13G/A
Oct 10, 2019
vanguard group inc
10.24%
20,064,602
SC 13G/A

IQV Fair Value

Iqvia Holdings fair value in different scenarios

The table shows the Fair Value estimates for Iqvia Holdings for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

78.94

-58.09%

100.31

-46.74%

138.31

-26.57%

183.07

-2.80%

226.36

20.18%
Current Inflation

72.25

-61.64%

90.39

-52.01%

122.07

-35.19%

159.28

-15.43%

195.23

3.65%
Very High Inflation

64.05

-65.99%

78.47

-58.34%

103.05

-45.29%

131.87

-29.99%

159.71

-15.21%

Historical Iqvia Holdings Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Iqvia Holdings

View All Filings
Date Filed Form Type Document
Feb 27, 2023
DEF 14A
DEF 14A
Feb 27, 2023
DEFA14A
DEFA14A
Feb 17, 2023
4
Insider Trading
Feb 17, 2023
PRE 14A
PRE 14A
Feb 15, 2023
10-K
Annual Report
Feb 15, 2023
4
Insider Trading
Feb 15, 2023
4
Insider Trading
Feb 15, 2023
4
Insider Trading
Feb 15, 2023
4
Insider Trading
Feb 15, 2023
4
Insider Trading

Latest Insider Trading transactions for IQV

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-02-16
Knightly Kevin C
sold
-1,003,070
225
-4,446
see remarks
2023-02-14
Sherbet Eric
sold
-230,000
230
-1,000
see remarks
2023-02-11
Cherofsky Keriann
sold (taxes)
-12,033
222
-54.00
see remarks
2023-02-11
Panagos Constantinos
sold (taxes)
-307,965
222
-1,382
see remarks
2023-02-10
Bruehlman Ronald E
sold (taxes)
-136,824
222
-614
see remarks
2023-02-10
BOUSBIB ARI
sold (taxes)
-779,049
222
-3,496
see remarks
2023-02-10
Cherofsky Keriann
sold (taxes)
-3,342
222
-15.00
see remarks
2023-02-10
Knightly Kevin C
sold (taxes)
-67,520
222
-303
see remarks
2023-02-10
Panagos Constantinos
sold (taxes)
-64,400
222
-289
see remarks
2023-02-10
Sherbet Eric
sold (taxes)
-72,645
222
-326
see remarks

1–10 of 50

Ari Bousbib
65535
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; virtual trials; and strategic planning and design services, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a strategic collaboration with HealthCore, Inc. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. IQVIA Holdings Inc. was founded in 1982 and is headquartered in Durham, North Carolina.

IQV Income Statement

2022-12-31
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Revenues$ 14,410$ 13,874$ 11,359
Cost of revenues, exclusive of depreciation and amortization9,3829,2337,500
Selling, general and administrative expenses2,0711,9641,789
Depreciation and amortization1,1301,2641,287
Restructuring costs282052
Income from operations1,7991,393731
Interest income(13)(6)(6)
Interest expense416375416
Loss on extinguishment of debt02613
Other expense (income), net33(130)(65)
Income before income taxes and equity in (losses) earnings of unconsolidated affiliates1,3631,128373
Income tax expense26016372
Income before equity in (losses) earnings of unconsolidated affiliates1,103965301
Equity in (losses) earnings of unconsolidated affiliates(12)67
Net income1,091971308
Net income attributable to non-controlling interests0(5)(29)
Net income attributable to IQVIA Holdings Inc.$ 1,091$ 966$ 279
Earnings per share attributable to common stockholders:   
Basic (in dollars per share)$ 5.82$ 5.05$ 1.46
Diluted (in dollars per share)$ 5.72$ 4.95$ 1.43
Weighted average common shares outstanding:   
Basic (in shares)187.6191.4191.3
Diluted (in shares)190.6195.0195.0

IQV Balance Sheet

2022-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
ASSETS  
Cash and cash equivalents$ 1,216$ 1,366
Trade accounts receivable and unbilled services, net2,9172,551
Prepaid expenses151156
Income taxes receivable4358
Investments in debt, equity and other securities93111
Other current assets and receivables561521
Total current assets4,9814,763
Property and equipment, net532497
Operating lease right-of-use assets331406
Investments in debt, equity and other securities6876
Investments in unconsolidated affiliates9488
Goodwill13,92113,301
Other identifiable intangibles, net4,8204,943
Deferred income taxes118124
Deposits and other assets, net472491
Total assets25,33724,689
Current liabilities:  
Accounts payable and accrued expenses3,3162,981
Unearned income1,7971,825
Income taxes payable161137
Current portion of long-term debt15291
Other current liabilities152207
Total current liabilities5,5785,241
Long-term debt, less current portion12,59512,034
Deferred income taxes464410
Operating lease liabilities264313
Other liabilities671649
Total liabilities19,57218,647
Commitments and contingencies (Note 1 and 12)
Stockholders’ equity:  
Common stock and additional paid-in capital, 400.0 shares authorized as of December 31, 2022 and 2021, $0.01 par value, 256.4 shares issued and 185.7 shares outstanding as of December 31, 2022; 255.8 shares issued and 190.6 shares outstanding as of December 31, 202110,89810,777
Retained earnings3,3342,243
Treasury stock, at cost, 70.7 and 65.2 shares as of December 31, 2022 and 2021, respectively(7,740)(6,572)
Accumulated other comprehensive loss(727)(406)
Total stockholders’ equity5,7656,042
Total liabilities and stockholders’ equity$ 25,337$ 24,689